For the first time, CMS proposes claims-based methods to identify 340B drugs billed to Medicare Part D | McDermott
MWE Logo
|

For the first time, CMS proposes claims-based methods to identify 340B drugs billed to Medicare Part D

Überblick

Lesen Sie hier den vollständigen Artikel

*Subscription required to access.